Cd4del/Cd4del
C57BR/cdJ-Cd4del
|
abnormal immune system organ morphology |
J:46692
|
abnormal lymph node T cell domain morphology |
J:46692
|
abnormal spleen morphology |
J:46692
|
absent CD4-positive, alpha-beta T cells |
J:46692
|
decreased IgG level |
J:46692
|
decreased IgM level |
J:46692
|
decreased immunoglobulin level |
J:46692
|
increased CD8-positive, alpha-beta T cell number |
J:46692
|
Cd4em1Litt/Cd4em1Litt
involves: C57BL/6J
|
normal
immune system phenotype |
J:333574
|
Cd4m1Btlr/Cd4m1Btlr
C57BL/6J-Cd4m1Btlr
|
absent CD4-positive, alpha-beta T cells |
J:212900
|
impaired humoral immune response |
J:212900
|
Cd4maat/Cd4maat
C57BL/6JAnu-Cd4maat/Apb
|
abnormal CD4-positive, alpha beta T cell morphology |
J:104190
|
abnormal double-positive T cell morphology |
J:104190
|
decreased CD4-positive, alpha-beta T cell number |
J:104190
|
increased CD8-positive, alpha-beta T cell number |
J:104190
|
Cd4sesh/Cd4sesh
C57BL/6JAnu-Cd4sesh/AnuApb
|
abnormal CD4-positive, alpha beta T cell morphology |
J:104190
|
abnormal double-positive T cell morphology |
J:104190
|
decreased T cell number |
J:104190
|
Cd4thth/Cd4thth
C57BL/6JSfdAnu-Cd4thth
|
absent CD4-positive, alpha-beta T cells |
J:104190
|
Cd4tm1Jrp/Cd4tm1Jrp
either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp
|
abnormal T cell differentiation |
J:45168
|
decreased CD4-positive, alpha-beta T cell number |
J:45168
|
decreased double-positive T cell number |
J:45168
|
increased CD8-positive, alpha-beta T cell number |
J:45168
|
Cd4tm1Knw/Cd4tm1Knw
B6.129S-Cd4tm1Knw/J
|
decreased CD4-positive, alpha-beta T cell number |
J:87828
|
increased CD8-positive, alpha-beta T cell number |
J:87828
|
increased susceptibility to parasitic infection |
J:87828
|
Cd4tm1Knw/Cd4tm1Knw
NOD.Cg-Cd4tm1Knw
|
decreased susceptibility to autoimmune diabetes |
J:93553
|
Cd4tm1Litt/Cd4tm1Litt
involves: 129S2/SvPas
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:50435
|
absent CD4-positive, alpha-beta T cells |
J:50435
|
decreased CD4-positive, alpha-beta T cell number |
J:158962
|
decreased T cell proliferation |
J:50435
|
increased CD8-positive, alpha-beta T cell number |
J:50435,
J:158962
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-cre)3778Nik/0
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:73479
|
abnormal interleukin-4 secretion |
J:73479
|
abnormal T-helper 2 physiology |
J:73479
|
decreased T cell proliferation |
J:73479
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-cre)3785Nik/0
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:73479
|
decreased CD4-positive, alpha-beta T cell number |
J:73479
|
increased CD8-positive, alpha-beta T cell number |
J:73479
|
increased T cell apoptosis |
J:73479
|
increased T cell proliferation |
J:73479
|
Cd4tm1Litt/Cd4tm1Nik Tg(Lck-icre)3779Nik/0
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:73479
|
decreased T cell proliferation |
J:73479
|
Cd4tm1Mak/Cd4tm1Mak
B6.129S2-Cd4tm1Mak/J
|
abnormal bile salt level |
J:133047
|
absent plasma cells |
J:133047
|
normal
immune system phenotype |
J:133047
|
Cd4tm1Mak/Cd4tm1Mak
involves: 129S2/SvPas
|
normal
immune system phenotype |
J:110749
|
Cd4tm1Mak/Cd4tm1Mak
involves: 129S2/SvPas * C57BL/6 * DBA/2
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:68957
|
demyelination |
J:92227
|
increased CD8-positive, alpha-beta T cell number |
J:68957
|
increased susceptibility to Picornaviridae infection |
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
PL.129S2(B6)-Cd4tm1Mak/Rdgz
|
brain inflammation |
J:92227
|
demyelination |
J:92227
|
increased susceptibility to Picornaviridae infection |
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
SJL.129S2(B6)-Cd4tm1Mak/Rdgz
|
brain inflammation |
J:92227
|
demyelination |
J:92227
|
increased susceptibility to Picornaviridae infection |
J:92227
|
Cd4tm1Nik/Cd4tm1Nik Tnfrsf4tm2(cre)Nik/Tnfrsf4+
involves: 129X1/SvJ
|
abnormal regulatory T cell physiology |
J:152472
|